<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03096678</url>
  </required_header>
  <id_info>
    <org_study_id>LBBB001</org_study_id>
    <nct_id>NCT03096678</nct_id>
  </id_info>
  <brief_title>Prognosis of Patients With Compete Left Bundle Branch Block</brief_title>
  <official_title>Morphological and Functional Changes, Risk Stratification and Prognosis of Patients With Compete Left Bundle Branch Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators sought to evaluate the morphological and functional changes, risk
      stratification and prognosis of patients of participants with compete left bundle branch
      block (CLBBB).

      The conduction of this study was largely due to the increased clinical requirement, which
      reflected the increased awareness among physicians of heart failure due to asynchronous
      cardiac function caused by CLBBB. The investigators also aim to figure out the time point or
      CMR parameters for cardiac resynchronization therapy in patients with CLBBB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of cardiac resynchronization therapy (CRT) for heart failure patients was
      heterogeneous. Candidate selection was important before intervention. The underlying
      mechanical dyssynchrony of left ventricular bundle branch block was insufficiently
      descripted. Earlier study of investigators found novel imaging methods such as cardiovascular
      magnetic resonance imaging including T1 Mapping and feature tracking imaging can provide more
      detailed information about regional and global LV function in patients. While the role of new
      cardiac MR imaging techniques in predicting CRT responses, especially in LBBB patients, is
      still insufficient. Z Chen et al used T1 mapping technique to quantitatively assess the
      diffuse fibrosis burden of myocardial in heart failure patients. But they found focal
      fibrosis burden, not diffuse burden, is associated with a poor response to CRT. Other cardiac
      MR imaging parameters also showed potential predictors of CRT, such as 16 segment
      time-to-maximum radial wall thickness , scar locations and RV septal lead placement.In this
      study cardiovascular magnetic resonance imaging (including T1 Mapping combined with feature
      tracking imaging ) will be applied to follow up LV function in LBBB patients (with or without
      intervention) in 10 years to find out prognostic predictors and time point or CMR parameters
      for cardiac resynchronization therapy in patients with CLBBB.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>All-cause death</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Transplantation</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICD Implantation</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pacemaker Implantation</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization due to heart failure</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Bundle-Branch Block, Left</condition>
  <condition>Cardiac Failure</condition>
  <condition>ICD/Pacemaker Implantation</condition>
  <condition>Cardiovascular Magnetic Resonance Imaging</condition>
  <arm_group>
    <arm_group_label>LBBB without LV dysfunction</arm_group_label>
    <description>LVEDD&gt;55mm or LVEF&lt;55%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LBBB with LV dysfunction</arm_group_label>
    <description>LVEDD&lt;55mm and LVEF&gt;55%</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiac Magnetic Resonance Imaging</intervention_name>
    <description>Using a comprehensive MR study (Function, LGE, Tissue Characterization, Strain, T1/T2 mapping) to predict the outcome of LBBB with different cardiac function.</description>
    <arm_group_label>LBBB without LV dysfunction</arm_group_label>
    <arm_group_label>LBBB with LV dysfunction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        subjects with complete left bundle branch block
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 18 years or older and able and willing to consent.

          -  The patient should present a complete left bundle branch block (LBBB) with QRS
             duration of &gt;120ms

          -  The patients should be in NYHA functional class I, II or III.

        Exclusion Criteria:

          -  No informed consent

          -  Permanent atrial fibrillation, flutter or tachycardia (&gt;100 bpm).

          -  Right bundle branch block

          -  Recent myocardial infarction, within 40 days prior to enrolment.

          -  Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90
             days.

          -  Implanted with a LV assist device (LVAD), or has reasonable probability (per
             investigator's discretion) of receiving a LVAD in the next year.

          -  Severe aortic stenosis (with a valve area of &lt;1.0 cm2 or significant valve disease
             expected to be operated on within study period).

          -  Complex and uncorrected congenital heart disease.

          -  Claustrophobia or devices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Minjie Lu, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical, Sciences and Peking Union Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Minjie Lu, MD,PhD</last_name>
    <phone>+861088398175</phone>
    <email>lumjcn@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jinhui Li, MD</last_name>
    <phone>+861088398158</phone>
    <email>ljhasuka@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuyu Chen, PhD</last_name>
      <phone>+86 10 88398175</phone>
      <email>fwchenxiuyu@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Flowers NC. Left bundle branch block: a continuously evolving concept. J Am Coll Cardiol. 1987 Mar;9(3):684-97. Review.</citation>
    <PMID>2950157</PMID>
  </reference>
  <reference>
    <citation>Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Biventricular pacing in heart failure: back to basics in the pathophysiology of left bundle branch block to reduce the number of nonresponders. Am J Cardiol. 2003 May 8;91(9A):55F-61F. Review.</citation>
    <PMID>12729851</PMID>
  </reference>
  <reference>
    <citation>Marsan NA, Westenberg JJ, Ypenburg C, van Bommel RJ, Roes S, Delgado V, Tops LF, van der Geest RJ, Boersma E, de Roos A, Schalij MJ, Bax JJ. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J. 2009 Oct;30(19):2360-7. doi: 10.1093/eurheartj/ehp280. Epub 2009 Jul 4.</citation>
    <PMID>19578165</PMID>
  </reference>
  <reference>
    <citation>Sohal M, Shetty A, Duckett S, Chen Z, Sammut E, Amraoui S, Carr-White G, Razavi R, Rinaldi CA. Noninvasive assessment of LV contraction patterns using CMR to identify responders to CRT. JACC Cardiovasc Imaging. 2013 Aug;6(8):864-73. doi: 10.1016/j.jcmg.2012.11.019. Epub 2013 Jun 2.</citation>
    <PMID>23735442</PMID>
  </reference>
  <reference>
    <citation>Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014 Jan 4;16:2. doi: 10.1186/1532-429X-16-2. Review.</citation>
    <PMID>24387626</PMID>
  </reference>
  <reference>
    <citation>Ambale-Venkatesh B, Lima JA. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2015 Jan;12(1):18-29. doi: 10.1038/nrcardio.2014.159. Epub 2014 Oct 28. Review.</citation>
    <PMID>25348690</PMID>
  </reference>
  <reference>
    <citation>Risum N, Tayal B, Hansen TF, Bruun NE, Jensen MT, Lauridsen TK, Saba S, Kisslo J, Gorcsan J 3rd, Sogaard P. Identification of Typical Left Bundle Branch Block Contraction by Strain Echocardiography Is Additive to Electrocardiography in Prediction of Long-Term Outcome After Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2015 Aug 11;66(6):631-41. doi: 10.1016/j.jacc.2015.06.020.</citation>
    <PMID>26248989</PMID>
  </reference>
  <reference>
    <citation>Aurich M, Keller M, Greiner S, Steen H, Aus dem Siepen F, Riffel J, Katus HA, Buss SJ, Mereles D. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking. Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1370-1378. Epub 2016 Mar 24.</citation>
    <PMID>27013249</PMID>
  </reference>
  <reference>
    <citation>Bogarapu S, Puchalski MD, Everitt MD, Williams RV, Weng HY, Menon SC. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy. Pediatr Cardiol. 2016 Apr;37(4):663-73. doi: 10.1007/s00246-015-1329-8. Epub 2016 Jan 30.</citation>
    <PMID>26833321</PMID>
  </reference>
  <reference>
    <citation>Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Hinojar R, Doltra A, Varma N, Child N, Rogers T, Suna G, Arroyo Ucar E, Goodman B, Khan S, Dabir D, Herrmann E, Zeiher AM, Nagel E; International T1 Multicentre CMR Outcome Study. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. JACC Cardiovasc Imaging. 2016 Jan;9(1):40-50. doi: 10.1016/j.jcmg.2015.12.001.</citation>
    <PMID>26762873</PMID>
  </reference>
  <reference>
    <citation>Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016 Jan;9(1):67-81. doi: 10.1016/j.jcmg.2015.11.005. Review.</citation>
    <PMID>26762877</PMID>
  </reference>
  <reference>
    <citation>van der Graaf AW, Bhagirath P, Scheffer MG, de Medina RR, Götte MJ. MR feature tracking in patients with MRI-conditional pacing systems: The impact of pacing. J Magn Reson Imaging. 2016 Oct;44(4):964-71. doi: 10.1002/jmri.25229. Epub 2016 Mar 17.</citation>
    <PMID>26990922</PMID>
  </reference>
  <reference>
    <citation>Witt CM, Wu G, Yang D, Hodge DO, Roger VL, Cha YM. Outcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular Function. JACC Heart Fail. 2016 Nov;4(11):897-903. doi: 10.1016/j.jchf.2016.07.002. Epub 2016 Sep 7.</citation>
    <PMID>27614941</PMID>
  </reference>
  <reference>
    <citation>Cerit L. Prediction of Readmission for Congestive Heart Failure With or Without Left Bundle Branch Block. Am J Cardiol. 2017 Jul 15;120(2):337. doi: 10.1016/j.amjcard.2017.01.010. Epub 2017 Feb 2.</citation>
    <PMID>28233534</PMID>
  </reference>
  <reference>
    <citation>Erne P, Iglesias JF, Urban P, Eberli FR, Rickli H, Simon R, Fischer TA, Radovanovic D. Left bundle-branch block in patients with acute myocardial infarction: Presentation, treatment, and trends in outcome from 1997 to 2016 in routine clinical practice. Am Heart J. 2017 Feb;184:106-113. doi: 10.1016/j.ahj.2016.11.003. Epub 2016 Nov 10.</citation>
    <PMID>28224924</PMID>
  </reference>
  <reference>
    <citation>Kawji MM, Glancy DL. Hypotension and Left Bundle Branch Block. Am J Cardiol. 2017 Apr 15;119(8):1292-1293. doi: 10.1016/j.amjcard.2016.11.070. Epub 2017 Jan 25.</citation>
    <PMID>28258731</PMID>
  </reference>
  <results_reference>
    <citation>Lu M, Zhao S, Jiang S, Yin G, Wang C, Zhang Y, Liu Q, Cheng H, Ma N, Zhao T, Chen X, Huang J, Zou Y, Song L, He Z, An J, Renate J, Xue H, Shah S. Fat deposition in dilated cardiomyopathy assessed by CMR. JACC Cardiovasc Imaging. 2013 Aug;6(8):889-98. doi: 10.1016/j.jcmg.2013.04.010. Epub 2013 Jul 10.</citation>
    <PMID>23850250</PMID>
  </results_reference>
  <results_reference>
    <citation>Lu M, Zhao S, Yin G, Jiang S, Zhao T, Chen X, Tian L, Zhang Y, Wei Y, Liu Q, He Z, Xue H, An J, Shah S. T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. Eur J Radiol. 2013 May;82(5):e225-31. doi: 10.1016/j.ejrad.2012.12.014. Epub 2013 Jan 17.</citation>
    <PMID>23333530</PMID>
  </results_reference>
  <results_reference>
    <citation>Lu M, Du H, Gao Z, Song L, Cheng H, Zhang Y, Yin G, Chen X, Ling J, Jiang Y, Wang H, Li J, Huang J, He Z, Zhao S. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study. Circ Cardiovasc Interv. 2016 Mar;9(3):e002675. doi: 10.1161/CIRCINTERVENTIONS.115.002675.</citation>
    <PMID>26884612</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2017</study_first_submitted>
  <study_first_submitted_qc>March 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2017</study_first_posted>
  <last_update_submitted>April 9, 2017</last_update_submitted>
  <last_update_submitted_qc>April 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Minjie Lu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Left Bundle Branch Block</keyword>
  <keyword>Regional/Globle cardiac function</keyword>
  <keyword>Mechanical asynchrony</keyword>
  <keyword>Cardiovascular Magnetic Resonance</keyword>
  <keyword>Outcome</keyword>
  <keyword>Cardiovascular events</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
    <mesh_term>Heart Block</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

